Recent Articles
Senate Bill S.4031 Signals a Federal Turn Toward Psychedelic Medicine
Senate bill S.4031 would establish VA Centers of Excellence to study psychedelic therapies — including MDMA, psilocybin, ibogaine, and ketamine — for veterans with PTSD, TBI, depression, and chronic pain. The bipartisan legislation, introduced by Sens. Gallego and McCormick, marks one of the most serious federal moves yet to bring psychedelic research inside a functioning healthcare institution.
By Joe Moore
Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots
By Joe Moore
Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines
By Jillian Gordon
Filter
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
What if classic psychedelic medicines like psilocybin don’t heal primarily by changing brain chemistry, but…
By Scott Shannon, MD – Wholeness Center, Fort Collins, Colorado
Couples Are Turning to Ketamine-Assisted Therapy to Heal Their Relationships
As couples’ therapists, we see the same painful sticking points again and again. Couples arrive…
By Chandra E. Khalifian, PhD, Skylar Kelsven, PhD, Kayla C. Knopp, PhD
Patient Safety After a Death: What Transparency Can and Cannot Do
A Tragedy at an Ibogaine Clinic — and the Policy Failure Behind It A patient…
By Joe Moore
Did New Jersey Really Just Legalize Psilocybin?
What S2283 Actually Does — and Why It Is a Research Pilot, Not Legalization In…
By Kyle Buller
From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public
Théo was stuck. At twenty-something, he had everything that should have made sense on paper:…
By Michelle Kronquist, Ciara Reynolds, Chiara Coppola, Leonie Staas, Annarita Eva
Psychedelic Medicine at the Edge of Science and Spirit
In recent years, something quietly disruptive has been occurring inside the world of modern psychedelic…